Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJ5N9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,564
Award facts
- Contract value 100% obligated
- $11,564.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a $11,564.36 firm fixed-price delivery order by the Defense Logistics Agency for Dupixent 300 mg/2 mL pens. The award, issued on January 22, 2026, with an ultimate completion date of January 23, 2026, was made without a set-aside designation, indicating full and open competition. This delivery order is a child contract under Cencora, Inc. (AmerisourceBergen's parent company), which holds a substantial Indefinite Delivery Contract valued at up to $999,999,999.00 with DLA Troop Support Medical through December 2031. This prime vehicle enables comprehensive pharmaceutical support for military healthcare programs worldwide.
Dupixent (dupilumab) is a specialty biologic medication used to treat moderate-to-severe atopic dermatitis and other inflammatory conditions, making this a critical pharmaceutical commodity for military healthcare systems. The delivery order structure and firm fixed pricing reflect standard practices for medical supply procurement through the DLA's pharmaceutical supply chain, which serves military treatment facilities, veteran healthcare programs, and other federal medical institutions. AmerisourceBergen's extensive portfolio of federal contracts and demonstrated capability to compete in open procurement processes underscore its established role as a key supplier of essential pharmaceutical and medical commodities to the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DR26FJ5N9?
SPE2DR26FJ5N9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FJ5N9 worth?
The government has obligated $11,564 on SPE2DR26FJ5N9.
Is contract SPE2DR26FJ5N9 an order under another contract?
Yes. SPE2DR26FJ5N9 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ5N9 competed?
The extent of competition for SPE2DR26FJ5N9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award